期刊文献+

联合用药方案治疗2型糖尿病的可行性研究

下载PDF
导出
摘要 目的对联合用药方案治疗2型糖尿病的可行性进行研究和分析。方法 100例2型糖尿病患者,采用数字抽签法分为实验组和对照组,各50例。对照组使用二甲双胍治疗,实验组在对照组基础上联合胰岛素治疗,并在治疗结束后对比分析两组的不良反应发生率和生化指标。结果实验组不良反应发生率为2.0%,低于对照组的14.0%(P<0.05);实验组治疗后的血糖、餐后2 h血糖、低密度脂蛋白、总胆固醇、甘油三酯均低于对照组(P<0.05)。结论联合用药方案治疗2型糖尿病具有可行性和安全性,值得在临床应用。
出处 《中国现代药物应用》 2016年第9期198-198,共1页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献5

二级参考文献54

  • 1邓少雄,郭南鸥.缬沙坦与氨氯地平治疗高血压病伴糖尿病临床分析[J].中国心血管病研究,2004,2(10):781-783. 被引量:8
  • 2DHILLON S. Sitagliptin : a review of its use in the mana-gement of type 2 diabetes mellitus [ J]. Drugs, 2010, 70(4) :489-512.
  • 3HERMAN G A, STEVENS C, VANDYCK K,et al. Phar-macokinetics and pharmacodynamics of sitagliptin,aninhibitor of dipeptidyl peptidase IV,in healthy subjects :results from two randomized,double-blind,placebo-controlled studies with single oral doses [ J]. ClinPharmacol Ther,2005,78(6) : 675-688.
  • 4BERGMAN A J, STEVENS C,ZHOU Y Y,et al. Phar-macokinetic and pharmacodynamic properties of multipleoral doses of sitagliptin, a dipeptidyl peptidase-IVinhibitor: a double-blind, randomized, placebo-controlledstudy in healthy male volunteers [ J] . Clin Ther,2006,28(1): 55-72.
  • 5MIGOYA E M, STEVENS C H, BERGMAN A J,et al.Effect of moderate hepatic insufficiency on thepharmacokinetics of sitagliptin [ J]. Can J Clin Pharmacol,2009,16(1): 165-170.
  • 6ASCHNER P, MICKEL C,KIPNES M S,et al. Effect of thedipeptidyl peptidase-4 inhibitor sitagliptin as monotherapyon glycemic control in patients with type 2 diabetes [ J].Diabetes Care,2006,29( 12) : 2632-2637.
  • 7RAZ I,HANEFELD M,XU L,et al. Efficacy and safety ofthe dipeptidyl peptidase-4 inhibitor sitagliptin asmonotherapy in patients with type 2 diabetes mellitus [ J].Diabetologia ,2006,49 (11) ; 2564-2571.
  • 8MOHAN V,YANG W,SON H Y,et al. Efficacy and safetyof sitagliptin in the treatment of patients with type 2 diabetes in China,India,and Korea [ J]. Diabetes Res ClinPract,2009,83(l) : 106-116.
  • 9NONAKA K,KAKIKAWA T,SATO A,et al. Efficacy andsafety of sitagliptin monotherapy in Japanese patients withtype 2 diabetes [ J] . Diabetes Res Clin Pract,2008,79(2):291-298.
  • 10ASCHNER P,KATZEFF H L,GUO H,et al. Efficacy andsafety of monotherapy of sitagliptin compared withmetformin in patients with type 2 diabetes [ J] . DiabetesObes Metab,2010,12(3) : 252-261.

共引文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部